Optimizing myasthenia gravis management in practice: integrating clinical scales and classification systems
Authors:
- José Pedro Soares BaimaJBJosé Pedro Soares Baima
- Caio César Diniz DisserolCDCaio César Diniz Disserol
- Eduardo Braga de OliveiraEOEduardo Braga de Oliveira
- Natália Merten AthaydeNANatália Merten Athayde
- Lara Albuquerque de BritoLBLara Albuquerque de Brito
- Hermany Capistrano FreitasHFHermany Capistrano Freitas
- Cleonisio Leite RodriguesCRCleonisio Leite Rodrigues
Open Access
- 12 May 2026
- journal article
- practical neurology
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (06) , 001-005
Abstract
Myasthenia gravis is an antibody-mediated disorder of the neuromuscular junction. Fatigability and fluctuations are hallmarks of the disease, posing a challenge: evaluation through a single physical examination may not reflect disease control. A shift towards patient-reported Outcomes is a new paradigm in the current practice, and these outcomes are usually assessed through validated scales. In the present paper, we discuss some of the most used scales in the clinical practice, such as the Myasthenia Gravis Foundation of America (MGFA) scale, the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale, and the 15-Item Myasthenia Gravis Quality of Life (MG-QOL15) scale. Definitions of remission, minimal manifestation, high-burden disease, highly-active disease, and others are reviewed, and correlations involving these definitions and the scales are presented. Guidance on how to assess disease severity, therapeutic response, and a rationale for treatment escalation are explored.Keywords
This publication has 13 references indexed in Scilit:
- Guideline for the management of myasthenic syndromesTherapeutic Advances in Neurological Disorders, 2023
- One‐year follow‐up of disease burden and medication changes in patients with myasthenia gravis: From the MG Patient RegistryMuscle & Nerve, 2022
- Myasthenia gravis in clinical practiceArquivos de Neuro-Psiquiatria, 2022
- Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature reviewNeurological Sciences, 2022
- Utilization of MG‐ADL in myasthenia gravis clinical research and careMuscle & Nerve, 2022
- Patient-acceptable symptom states in myasthenia gravisNeurology, 2020
- Measuring Clinical Treatment Response in Myasthenia GravisNeurologic Clinics, 2018
- Quantitative Myasthenia Gravis Score: a Brazilian multicenter study for translation, cultural adaptation and validationArquivos de Neuro-Psiquiatria, 2017
- Brazilian-Portuguese translation, cross-cultural adaptation and validation of the Myasthenia Gravis Composite scale. A multicentric studyArquivos de Neuro-Psiquiatria, 2016
- Brazilian cross-cultural translation and adaptation of the "Questionnaire of Life Quality Specific for Myasthenia Gravis - 15 items"Arquivos de Neuro-Psiquiatria, 2013